Global Blood Therapeutics director resigns
Insight Weekly: US bank stress tests; cracks in housing market; summer energy supply risks
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Michael Bonney will resign as a board member of Global Blood Therapeutics Inc. at the next annual meeting of stockholders to be held June 20.
Bonney's decision to resign was not the result of any disagreement on any matters relating to the company's operations, policies or practices.